SFDA CEO Launches an AI Model to Proactively Predict Drug Shortages in Saudi Arabia

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, launched an AI-powered model for predicting drug shortages in the Kingdom of Saudi Arabia. The launch took place during the Global Health Exhibition, held from October 27 to 30. It highlights the SFDA's commitment to enhance drug monitoring and proactively address any potential shortages.

This AI model is one of the first innovative smart solutions globally designed for predicting drug shortages. It relies on advanced algorithms to continuously analyze historical data for each drug, generating accurate predictions that facilitate immediate decision-making to prevent any potential shortages.

This initiative represents a transformative leap in the national drug security system. It contributes to increased efficiency in supply chain management and ensures that medications reach patients in a timely manner. The AI model also reflects the SFDA's commitment to utilizing modern technologies to serve public health and enhance Saudi Arabia’s global competitiveness in the pharmaceutical sector, aligning with the digital transformation objectives of Saudi Vision 2030.